SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cypress Bioscience Inc – ‘10-K’ for 12/31/09 – ‘EX-32’

On:  Tuesday, 3/30/10, at 9:40pm ET   ·   As of:  3/31/10   ·   For:  12/31/09   ·   Accession #:  950123-10-30260   ·   File #:  0-12943

Previous ‘10-K’:  ‘10-K’ on 3/16/09 for 12/31/08   ·   Latest ‘10-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/31/10  Cypress Bioscience Inc            10-K       12/31/09   10:795K                                   Donnelley … Solutions/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    594K 
 2: EX-10.18    Material Contract                                   HTML     38K 
 3: EX-10.19    Material Contract                                   HTML     13K 
 4: EX-10.20    Material Contract                                   HTML     18K 
 5: EX-10.21    Material Contract                                   HTML     25K 
 6: EX-21.1     Subsidiaries                                        HTML      6K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
 8: EX-31.1     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     12K 
 9: EX-31.2     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     12K 
10: EX-32       Certification -- Sarbanes-Oxley Act - Sect. 906     HTML     10K 


EX-32   —   Certification — Sarbanes-Oxley Act – Sect. 906


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  exv32  

Exhibit 32
CERTIFICATION PURSUANT TO SECTION 906*
     In connection with the accompanying Annual Report of Cypress Bioscience, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2009 (the “Report”), I, Jay D. Kranzler, Chief Executive Officer of the Company, and I, Sabrina Martucci Johnson, Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 30, 2010
 C:  C:  C:  C: 
             
      /s/ SABRINA MARTUCCI JOHNSON    
 
           
Chief Executive Officer
      Chief Financial Officer    
 
*   This certification accompanies the Report to which it relates, is not deemed “filed” with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company made under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, except to the extent that the Company specifically incorporates this certification by reference therein.

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:3/31/1010-Q,  8-K
Filed on:3/30/10
For Period End:12/31/09NT 10-K
 List all Filings 
Top
Filing Submission 0000950123-10-030260   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 9:40:06.1am ET